awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47193937-89F9588C-9622-47CC-9F32-21EAF30856F6
Q47193937-89F9588C-9622-47CC-9F32-21EAF30856F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47193937-89F9588C-9622-47CC-9F32-21EAF30856F6
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations.
P2860
Q47193937-89F9588C-9622-47CC-9F32-21EAF30856F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47193937-89F9588C-9622-47CC-9F32-21EAF30856F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d395cf2366a23154acf1a44f494fdedc42f70fdc
P2860
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.